Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide life sciences, agriculture, food & beverage, and other key industries, participated in yesterday’s Emerging Growth Conference. PBIO was one of 11 companies presenting at the conference; PBIO’s president and CEO Richard T. Schumacher led the presentation and provided an overview of the company and its long-term CBD stability and astaxanthin processing breakthroughs using its proprietary Ultra Shear Technology(TM). Schumacher also provided an update on the company’s upcoming acquisition of assets of a global eco-friendly agrochemicals company. According to the press release, astaxanthin is one of the world's most potent antioxidants and can be used in pharmaceutical, nutraceutical, cosmetic, food & beverage, and animal feed industries. Because it is plant oil based, the substance is difficult to absorb, but PBIO’s UST-processed nanoemulsions of astaxanthin oil have the potential to significantly increase its water solubility and bioavailability; in addition, the technology save costs and extends the shelf-life of the substances, which makes more precise dosing possible. The market is estimated to be a billion-dollar industry. PBIO’s UST-processed nanoemulsions of CBD oil in water last more than 14 months of long-term stability, opening up what the company called “explosive growth potential for UST-processed CBD-infused beverages.” This conference provides unparalleled content in identifying emerging growth companies and markets that are sometimes overlooked by the investment community. Investors, analysts and advisors attend the conference to hear about publicly traded companies and their new products, services and other major announcements to the investment community in an effective and time efficient manner.
To view the full press release, visit https://ibn.fm/FQkBu
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) (“PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of the company’s pressure-based technologies in the following areas: (1) the use of PBIO’s recently acquired, patented technology from BaroFold Inc. to allow entry into the biopharma contract services sector and (2) the use of PBIO’s recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to prepare higher-quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information about the company, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.